Kamada (KMDA) Cash from Operations (2012 - 2026)
Kamada's (KMDA) quarterly Cash from Operations came in at 291000.0 in Q1 2026, up 43.27% YoY from 203106.12 in Q1 2025, and down 103.85% on a QoQ basis from 7566000.0 in Q4 2025.
Kamada (KMDA) Cash from Operations (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Cash from Operations data on file, last reported at 291000.0 in Q1 2026.
- Quarterly Cash from Operations rose 43.27% year-over-year to 291000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25712000.0 (down 44.18% YoY) and the FY2025 annual result came in at 25490000.0, down 46.44% from the prior year.
- Cash from Operations fell to 291000.0 in Q1 2026, from 7566000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 22213000.0 in Q3 2024 to a low of 513000.0 in Q1 2025.
- A 5-year average of 5764904.88 and a median of 5465000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 90525.93% — and 2025, when it sank 150.29%.
- Tracing KMDA's Cash from Operations over 5 years: stood at 6742.0 in 2022, then surged by 90525.93% to 6110000.0 in 2023, then soared by 70.18% to 10398000.0 in 2024, then slipped by 27.24% to 7566000.0 in 2025, then slumped by 103.85% to 291000.0 in 2026.
- The last three Cash from Operations figures came in at 291000.0 (Q1 2026), 7566000.0 (Q4 2025), and 10416000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kamada | 473.85 Mn | 444.38 Mn | 22.47 Mn | 18.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.07 Mn |
| Jun 30, 2026 | 18.07 Mn |
| Mar 31, 2026 | -291,000.00 |
| Mar 31, 2026 | -291,000.00 |
| Dec 31, 2025 | 7.57 Mn |
| Dec 31, 2025 | 7.57 Mn |
| Sep 30, 2025 | 10.42 Mn |
| Sep 30, 2025 | 10.42 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Mar 31, 2025 | -513,000.00 |
| Mar 31, 2025 | -513,000.00 |
| Dec 31, 2024 | 10.40 Mn |
| Dec 31, 2024 | 10.40 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Jun 30, 2024 | 13.96 Mn |
| Jun 30, 2024 | 13.96 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.02 Mn |